9 Meters Biopharma, Inc. MNTRQ

Market cap
$1.0M
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22
P/E ratio
0.00 — — — — — —
P/S ratio
2.38 — — — — — —
P/FCF ratio
0.00 — — — — — —
P/Operating CF
(4.41) — — — — — —
P/B ratio
3.88 — — — — — —
EV/Sales
2.10 — — — — — —
EV/EBITDA
0.00 — — — — — —
EV/FCF
(1.01) — — — — — —
Current Ratio
1.01 0.06 0.63 0.35 5.68 5.91 1.08
Net Debt/EBITDA
0.34 (0.74) 0.03 0.06 0.64 1.28 (0.17)
Debt/Equity
0.02 (0.70) (1.42) (0.34) 0.00 0.00 8.20
ROE
387.59% 239.63% 305.20% 407.57% (545.95%) (99.75%) (198.92%)
ROA
(111.13%) (319.61%) (666.30%) (460.37%) (276.67%) (82.34%) (105.05%)
ROIC
(346.17%) 0.00% 0.00% 0.00% 0.00% 0.00% (278.41%)
Return on Tangible Assets
(10,900.00%) 95.28% 659.33% 279.94% (191.64%) (88.53%) (1,876.45%)
Average Days of Receivables
76.86 0.00 — — — — —
Earnings Yield
(50.86%) — — — — — —
Free Cash Flow Yield
(87.24%) — — — — — —
Free Cash Flow per Share
(305.33) (8.64) (12.26) (10.79) (3.68) (2.43) (2.87)
Book value per Share
90.14 (20.48) (2.96) (5.77) 6.09 3.42 0.19
Free Cash Flow
(8.43) (5.14) (15.18) (17.98) (19.41) (29.49) (37.25)
EV/EBIT
0.00 — — — — — —
Other line items

Show all line items

Columns are period end dates